Overview
The 5th ISCAYAHL will focus on discussion of the main questions in the field of pediatric, adolescent and young adult (AYA) Hodgkin lymphoma (HL) such as survivorship outcomes, clinical trial portfolios from around the world, novel therapeutics biomarkers and biology and novel imaging of pediatric HL. The goal of this conference is to provide a platform to share work from global collaborations and form new ones.
The International Symposium for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (ISCAYAHL) was first assembled by Dr. Monika Metzger, USA and Dr. Mauz-Körholz, Germany as a chance to engage the global pediatric HL scientific community. The first meeting was held in Arlington, Virginia, USA May 12-14th 2011. During this meeting new collaborations and research opportunities arose. Leaders from various pediatric collaborative groups including Children’s Oncology group (COG), European Network for Pediatric HL (EuroNet-PHL), the Pediatric Hodgkin Consortium (PHC) and Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA) recognized a profound need to not only standardize response criteria, but also staging criteria to facilitate the interpretation and comparison of clinical studies worldwide. Out of this formed the ongoing Staging Evaluation and Response Criteria Harmonization (SEARCH) initiative.
Mission
To improve survival and quality of life for all children, adolescents and young adults with Hodgkin lymphoma worldwide through collaboration.
Registration
- Regular registration is now open through the meeting.
- In-person only (at present time)
- Cost: $399 and $249 for LMIC and Trainees/YIs
- Yoga: Sign up for Saturday when registering
- Ask about: daycare, breastfeeding/mother’s room, religious needs, other accommodations
Abstract submission deadline: July 28, 2023
Agenda
| Wednesday, October 18, 2023 (CLOSED MEETINGS) | |
|---|---|
| 11:00 a.m.-1:00 p.m. | Registration Opens |
| 1:00-4:00 p.m. | Closed Clinical Board Meetings: Parallel sessions-COG, EuroNet, PHC |
| 4:00-5:00 p.m. | Closed Session: Coming Together |
| 5:00-6:00 p.m. | Closed Networking - Wine, cheese, and appetizers |
| Thursday, October 19, 2023 | |
| 8:00-9:30 a.m. | Survivorship Co-chairs: Margareet Veening, Matt Ehrhardt |
| 9:30-9:45 a.m. | BREAK |
| 9:45 a.m.-12:00 p.m. | Clinical Trials Update Co-chairs: Kara Kelly, Dieter Koerholz |
| 12:00-1:00 p.m. | LUNCH - Networking tables 12:15 pm - Survivor Panel Discussion |
| 1:00-2:30 p.m. | Radiation Oncology/Imaging Co-chairs: Karin Dieckmann, Ray Mailhot |
| 2:30-2:45 p.m. | BREAK |
| 2:45-4:15 p.m. | SEARCH for CAYAHL / Harmonization Updates Co-chairs: Jennifer Seelisch, Lars Kurch |
| 4:15-4:30 p.m. | BREAK |
| 4:30-5:15 p.m. | Poster Pitch Day 1 |
| 5:30-6:15 p.m. | Keynote Lecture: Richard Hoppe Cocktails and appetizers; reception to continue after the lecture |
| Friday, October 20, 2023 | |
| 8:00-8:45 a.m. | Meet the Expert Cases Co-chairs: Kathleen McCarten, Dietrich Stoeveant |
| 8:45-9:00 a.m. | BREAK |
| 9:00-10:15 a.m. | Health Outcomes Co-chars: Angela Feraco, Ajay Major |
| 10:15-10:30 a.m. | BREAK |
| 10:30 a.m.-12:00 p.m. | Novel Therapeutics / Cellular Therapies Co-chairs: George Hucks, Matthieu Simonin |
| 12:00-1:00 p.m. | LUNCH - Networking tables |
| 1:00-3:00 p.m. | Translational Biology |
| 3:00-3:15 p.m. | BREAK |
| 3:15-5:00 p.m. | Global Initiatives / Global Trials Co-chairs: Pedro DeAlarcon, Mario DePaulo |
| 5:15-6:00 p.m. | Poster Pitch Day 2 Cocktails and appetizers; reception to continue after. |
| 7:00 p.m. | Symposium Dinner |
| Saturday, October 21, 2023 | |
| 7:00-8:00 a.m. | Yoga |
| 9:00-10:30 a.m. | Adolescents & Young Adults Co-chairs: Maurizio Mascarin, Adam Duvall |
| 10:30-10:45 a.m. | BREAK |
| 10:45 a.m.-12:15 p.m. | Relapse Treatment & Challenging Cases Co-chairs: Chris Forlenza, Alexander Claviez |
| 12:15 p.m. | Closing & Awards |
| 1:30 p.m. | St. Jude Tour |
CME Information
-
- Health care providers involved in the acute care of children, adolescents and young adults with Hodgkin lymphoma or long-term follow-up of survivors
- Basic researchers interested in the biology of Hodgkin lymphoma
-
St. Jude Children’s Research Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
St. Jude Children’s Research Hospital designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
-
- Develop standards of care for children, adolescents, and young adults (AYA) with Hodgkin lymphoma (HL) globally
- Review clinical science and trial advances for pediatric and AYA HL to harmonize future iterations of trial development
- Advance use of patient-reported outcomes in HL to improve personalized approaches to care
- Utilize current state of survivorship research to inform therapeutic advances in HL
-
ISCAYAHL 2023 Scientific Committtee
Co-Chairs
Jamie Flerlage | USA
Christine Mauz-Körholz | Germany
Sharon Castellino | USA
Auke Beishuzen | The Netherlands
Catherine Bollard | USA
Andreas Braeuninger | Germany
Stephan Daw | UK
Mario DePaula | Brazil
Karin Dieckmann | Austria
Matt Ehrhardt | USA
Andrew Evans | USA
Angela Feraco | USA
Stefan Gattenlöhner | Germany
Lisa Giulino Roth | USA
Brad Hoppe | USA
Melissa Hudson | USA
Kara Kelly | USA
Tomasz Klekawka | Poland
Regine Kluge | Germany
Dieter Körholz | Germany
Judith Landman-Parker | France
Thierry Leblanc | France
Megan Lim | USA
Andrea Lo | Canada
John Lucas | USA
Maurizio Mascarin | Italy
Kathleen McCarten | USA
Marius Rohde | Germany
Jennifer Seelisch | Canada
Christian Steidl | Canada
Dietrich Stoevesandt | Germany
Leanne Super | Australia
Anke van den Berg | The Netherlands
David Veron | Argentina